NEW YORK (Standard&Poor's) Jan. 3, 2011--Standard&Poor's Ratings Services said today that CVS Caremark Corp.'s (BBB+/Negative/A-2) announcement that it has entered into an agreement to acquire the Medicare Part D business of Universal American Corp. for approximately $1.25 billion does not affect our ratings or outlook on the company. Universal American is a Medicare Prescription Drug Plan (PDP) sponsor. With this acquisition, CVS Caremark will more than double the size of its Medicare Part D program, enhancing its position in the PDP Medicare segment. CVS expects this transaction to be accretive to earnings per share in its first full year. We do not expect this transaction to have a meaningful impact on CVS Caremark's credit measures given
